TRIPAN 5mg Film-coated tablet Ref.[50693] Active ingredients: Tadalafil

Source: Υπουργείο Υγείας (CY)  Revision Year: 2020  Publisher: Delorbis Pharmaceuticals ltd., 17 Athinon Street, Ergates Industrial Area, 2643 Ergates, P.O. Box 28629, 2081 Lefkosia, Cyprus, European Union

Product name and form

Tripan 5 mg film-coated tablets.

Pharmaceutical Form

Film-coated tablet (tablet).

Light brown, oblong, biconvex, film-coated tablets.

Qualitative and quantitative composition

Each tablet contains 5 mg tadalafil.

Excipient with known effect: Each coated tablet contains 77 mg lactose (as monohydrate).

For the full list of excipients, see section 6.1.

Active Ingredient Description
Tadalafil

Tadalafil is a selective, reversible inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). When sexual stimulation causes the local release of nitric oxide, inhibition of PDE5 by tadalafil produces increased levels of cGMP in the corpus cavernosum. This results in smooth muscle relaxation and inflow of blood into the penile tissues, thereby producing an erection. The effect of PDE5 inhibition on cGMP concentration in the corpus cavernosum is also observed in the smooth muscle of the prostate, the bladder and their vascular supply. The resulting vascular relaxation increases blood perfusion which may be the mechanism by which symptoms of benign prostatic hyperplasia are reduced.

List of Excipients

Tablet core:

Lactose monohydrate
Microcrystalline cellulose
Povidone K-30
Poloxamer type 188
Sodium lauryl sulfate
Croscarmellose sodium
Silica colloidal anhydrous
Magnesium stearate

Film-coat:

Polyvinyl alcohol
Macrogol
Talc
Titanium dioxide (E171)
Iron oxide yellow (E172)
Iron oxide red (E172)

Pack sizes and marketing

Aluminium/PVC/PVDC blisters in cartons of 14, 28, 30 and 84 film-coated tablets.

Not all packs sizes may be marketed.

Marketing authorization holder

Delorbis Pharmaceuticals ltd., 17 Athinon Street, Ergates Industrial Area, 2643 Ergates, P.O. Box 28629, 2081 Lefkosia, Cyprus, European Union

Marketing authorization dates and numbers

M.L.: 023089

26/03/2020

Drugs

Drug Countries
TRIPAN Cyprus, Malta

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.